References
- Barr J, Fraser G, Puntillo K. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.
- Patanwala A, Martin J, Erstad B. Ketamine for analgosedation in the intensive care unit: a systematic review. J Intensiv Care Med. 2015;32(6):387–95
- Fine P. Ketamine: from anesthesia to palliative care. Newsletter of the AAHPM. 2003;3(3):6.
- Sakai T, Baba S, Ishihara H, Matsuki A, Oyama T. Sudden diabetes insipidus induced by ketamine infusion. Agressologie. 1986;27(6):499–500.
- Hatab S, Singh A, Felner E, Kamat P. Transient central diabetes insipidus induced by ketamine infusion. Ann Pharmacother. 2014;48(12):1642–45.
- Gaffar S, Eskander J, Beakley B, McClure B, Amenta P, Pierre N. A case of central diabetes insipidus after ketamine infusion during an external to internal carotid artery bypass. J Clin Anesth. 2017;36:72–75.
- Shapiro M, Weiss J. Diabetes insipidus: a review. Diabetes Metab. 2012;20(1):9–21
- Swenson KL, Badre SE, Morsette DJ, Sladek CD. N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. J Neuroendocrinol. 1998;10(9):679–85.
- Orlowska-Majdak M, Traczyk W, Szymanski D. Hippocampal vasopressin release evoked by N-methyl-D-aspartate (NMDA) microdialysis. Physiol Res. 2003;52(3):373–82.
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.